Shruthi Sriramkumar

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Top Venues

Molecular cancer research : MCR

Cancer research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Vaishnavi Muralikrishnan, Fang Fang, Tyler C Given, Ram Podicheti, Mikhail Chtcherbinine, Tara X Metcalfe, Shruthi Sriramkumar, Heather M O'Hagan, Thomas D Hurley, Kenneth P Nephew
A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer. Cancers 14 (14) (2022)
Christina E DeStefano Shields, James R White, Liam Chung, Alyssa Wenzel, Jessica L Hicks, Ada J Tam, June L Chan, Christine M Dejea, Hongni Fan, John Michel, Ashley R Maiuri, Shruthi Sriramkumar, Ram Podicheti, Douglas B Rusch, Hao Wang, Angelo M DeMarzo, Sepideh Besharati, Robert A Anders, Stephen B Baylin, Heather M O'Hagan, Franck Housseau, Cynthia L Sears
Bacterial-Driven Inflammation and Mutant BRAF Expression Combine to Promote Murine Colon Tumorigenesis That Is Sensitive to Immune Checkpoint Therapy. Cancer discovery 11 (7) (2021)
Samuel A Miller, Robert A Policastro, Shruthi Sriramkumar, Tim Lai, Thomas D Huntington, Christopher A Ladaika, Daeho Kim, Chunhai Hao, Gabriel E Zentner, Heather M O'Hagan
LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer. Cancer research 81 (14) (2021)
Shruthi Sriramkumar, Timothy D Matthews, Ahmed H Ghobashi, Samuel A Miller, Pamela S VanderVere-Carozza, Katherine S Pawelczak, Kenneth P Nephew, John J Turchi, Heather M O'Hagan
Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer. Molecular cancer research : MCR 18 (11) (2020)
Samuel A Miller, Robert A Policastro, Sudha S Savant, Shruthi Sriramkumar, Ning Ding, Xiaoyu Lu, Helai P Mohammad, Sha Cao, Jay H Kalin, Philip A Cole, Gabriel E Zentner, Heather M O'Hagan
Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in PIK3CA-Mutant Colorectal Cancer. Molecular cancer research : MCR 18 (2) (2019)